BioRestorative Therapies (BRTX) Other Accumulated Expenses (2012 - 2025)
BioRestorative Therapies' (BRTX) quarterly Other Accumulated Expenses came in at $982047.0 in Q4 2025, up 31.91% YoY from $744485.0 in Q4 2024, and up 61.66% on a QoQ basis from $607470.0 in Q3 2025.
BioRestorative Therapies (BRTX) Other Accumulated Expenses (2012 - 2025) Analysis & Trends
BioRestorative Therapies (BRTX) has 10 years of Other Accumulated Expenses data on file, last reported at $982047.0 in Q4 2025.
- Quarterly Other Accumulated Expenses rose 31.91% year-over-year to $982047.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $982047.0 (up 31.91% YoY) and the FY2025 annual result came in at $982047.0, up 31.91% from the prior year.
- Other Accumulated Expenses grew to $982047.0 in Q4 2025, from $607470.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $982047.0 in Q4 2025 to a low of $277610.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | BioRestorative Therapies | 1.94 Mn | -1.02 Mn | 17,964.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 982,047.00 |
| Sep 30, 2025 | 607,470.00 |
| Jun 30, 2025 | 480,925.00 |
| Mar 31, 2025 | 277,610.00 |
| Dec 31, 2024 | 744,485.00 |
| Sep 30, 2019 | 628,976.00 |
| Jun 30, 2019 | 505,210.00 |
| Mar 31, 2019 | 402,065.00 |
| Dec 31, 2018 | 338,619.00 |
| Sep 30, 2018 | 333,514.00 |
| Jun 30, 2018 | 339,597.00 |
| Mar 31, 2018 | 405,478.00 |
| Dec 31, 2017 | 329,166.00 |
| Sep 30, 2017 | 262,894.00 |
| Jun 30, 2017 | 198,111.00 |
| Mar 31, 2017 | 164,117.00 |
| Dec 31, 2016 | 127,375.00 |
| Jun 30, 2016 | 65,891.00 |
| Mar 31, 2016 | 34,586.00 |
| Dec 31, 2015 | 6,823.00 |